{"id":"https://openalex.org/W3082465831","doi":"https://doi.org/10.1158/1538-7755.disp19-d073","title":"Abstract D073: Combination of insulin-like growth factor-1 receptor/insulin receptor (IGF1R/IR) and androgen receptor (AR) antagonists with metformins inhibits triple-negative breast cancer (TNBC) progression in vitro and in vivo","display_name":"Abstract D073: Combination of insulin-like growth factor-1 receptor/insulin receptor (IGF1R/IR) and androgen receptor (AR) antagonists with metformins inhibits triple-negative breast cancer (TNBC) progression in vitro and in vivo","publication_year":2020,"publication_date":"2020-06-01","ids":{"openalex":"https://openalex.org/W3082465831","doi":"https://doi.org/10.1158/1538-7755.disp19-d073","mag":"3082465831"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7755.disp19-d073","doi":"https://doi.org/10.1158/1538-7755.disp19-d073","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7755.disp19-d073","pdf_url":null,"source":{"id":"https://openalex.org/S8391440","display_name":"Cancer Epidemiology Biomarkers & Prevention","issn_l":"1055-9965","issn":["1055-9965","1538-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Epidemiology, Biomarkers &amp; Prevention","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018042582","display_name":"Nalo M. Hamilton","orcid":"https://orcid.org/0000-0002-6717-8079","observed_orcids":["https://orcid.org/0000-0002-6717-8079"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nalo M. Hamilton","raw_affiliation_strings":["1UCLA School of Nursing, Los Angeles, California, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA School of Nursing, Los Angeles, California, USA,","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068958299","display_name":"Diana C. M\u00e1rquez\u2010Garb\u00e1n","orcid":"https://orcid.org/0000-0002-4693-3063","observed_orcids":["https://orcid.org/0000-0002-4693-3063"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diana C. M\u00e1rquez-Garb\u00e1n","raw_affiliation_strings":["*Authors contributed equally","2UCLA David Geffen School of Medicine, Los Angeles, California, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"*Authors contributed equally","institution_ids":[]},{"raw_affiliation_string":"2UCLA David Geffen School of Medicine, Los Angeles, California, USA,","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064589097","display_name":"Michael E. Jung","orcid":"https://orcid.org/0000-0003-1290-8588","observed_orcids":["https://orcid.org/0000-0003-1290-8588"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael E. Jung","raw_affiliation_strings":["3UCLA Department of Chemistry and Biochemistry, Los Angeles, California, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3UCLA Department of Chemistry and Biochemistry, Los Angeles, California, USA,","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012585441","display_name":"Jaydutt V. Vadgama","orcid":"https://orcid.org/0000-0002-0019-8622","observed_orcids":["https://orcid.org/0000-0002-0019-8622"]},"institutions":[{"id":"https://openalex.org/I52710748","display_name":"Charles R. Drew University of Medicine and Science","ror":"https://ror.org/038x2fh14","country_code":"US","type":"education","lineage":["https://openalex.org/I52710748"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaydutt Vadgama","raw_affiliation_strings":["4Charles Drew University School of Medicine and Science, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Charles Drew University School of Medicine and Science, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I52710748"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034694412","display_name":"Richard J. Pietras","orcid":"https://orcid.org/0000-0002-2846-3192","observed_orcids":["https://orcid.org/0000-0002-2846-3192"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard J. Pietras","raw_affiliation_strings":["2UCLA David Geffen School of Medicine, Los Angeles, California, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UCLA David Geffen School of Medicine, Los Angeles, California, USA,","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"6_Supplement_2","first_page":"D073","last_page":"D073"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.7289999723434448,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.7289999723434448,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.17430000007152557,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.04439999908208847,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/androgen-receptor-antagonists","display_name":"androgen receptor antagonists","score":0.9649999737739563},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.8429999947547913},{"id":"https://openalex.org/keywords/bms-754807","display_name":"BMS-754807","score":0.9300000071525574},{"id":"https://openalex.org/keywords/nvp-aew541","display_name":"NVP-AEW541","score":0.9789999723434448},{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6890000104904175},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7480000257492065},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.7409999966621399},{"id":"https://openalex.org/keywords/cell-migration","display_name":"cell migration","score":0.9660000205039978},{"id":"https://openalex.org/keywords/reactive-oxygen-species","display_name":"reactive oxygen species","score":0.9850000143051147},{"id":"https://openalex.org/keywords/tumor-cell-apoptosis","display_name":"tumor cell apoptosis","score":0.5299999713897705},{"id":"https://openalex.org/keywords/ampk","display_name":"AMPK","score":0.7710000276565552}],"concepts":[{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.8169058561325073},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.6720858216285706},{"id":"https://openalex.org/C144174609","wikidata":"https://www.wikidata.org/wiki/Q14901457","display_name":"Insulin-like growth factor 1 receptor","level":4,"score":0.6491130590438843},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5873327851295471},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.5772809982299805},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5497817993164062},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5423974990844727},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4521957337856293},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.45002347230911255},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4490917921066284},{"id":"https://openalex.org/C2780689927","wikidata":"https://www.wikidata.org/wiki/Q24766801","display_name":"Insulin-like growth factor","level":4,"score":0.44321373105049133},{"id":"https://openalex.org/C2780124434","wikidata":"https://www.wikidata.org/wiki/Q12357464","display_name":"AMPK","level":4,"score":0.4362279772758484},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.3804248571395874},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36584532260894775},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3608349561691284},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.27613168954849243},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.19261124730110168},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.12971290946006775},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7755.disp19-d073","doi":"https://doi.org/10.1158/1538-7755.disp19-d073","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7755.disp19-d073","pdf_url":null,"source":{"id":"https://openalex.org/S8391440","display_name":"Cancer Epidemiology Biomarkers & Prevention","issn_l":"1055-9965","issn":["1055-9965","1538-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Epidemiology, Biomarkers &amp; Prevention","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3082035237","https://openalex.org/W2765923361","https://openalex.org/W2492024737","https://openalex.org/W2945087752","https://openalex.org/W3087399005","https://openalex.org/W3179906821","https://openalex.org/W2499144023","https://openalex.org/W4324306058","https://openalex.org/W2137993244","https://openalex.org/W2305574656"],"abstract_inverted_index":{"Abstract":[0],"Triple-negative":[1],"breast":[2,12,357],"cancer":[3,13,358],"(TNBC)":[4,359],"affects":[5],"only":[6],"about":[7],"15%":[8],"of":[9,20,28,52,87,114,120,143,160,179,200,221,341,369,377],"women":[10],"with":[11,49,130,170,173,185,294,299,353],"(BC)":[14],"but":[15],"accounts":[16],"for":[17,31,66],"almost":[18],"50%":[19],"all":[21],"BC":[22],"deaths.":[23],"At":[24],"this":[25],"time,":[26],"development":[27],"targeted":[29],"treatments":[30,193,239,285],"TNBC":[32,58,88,124,151,164,180,204,297],"is":[33],"urgently":[34],"needed.":[35],"Insulin-like":[36],"growth":[37,68,343],"factors":[38],"and":[39,73,82,122,148,158,172,202,288,292,348,363,384],"diabetes":[40],"mellitus":[41],"type":[42],"2":[43],"are":[44,77,268],"noted":[45],"to":[46,79,83,206,217,244,271,301],"be":[47,80],"associated":[48],"increased":[50],"incidence":[51],"estrogen":[53],"receptor-negative":[54],"BCs":[55],"such":[56],"as":[57],"particularly":[59],"among":[60],"African":[61],"American":[62],"patients.":[63],"Since":[64],"receptors":[65],"insulin-like":[67,342],"factor-1":[69,344],"receptor/insulin":[70,345],"receptor":[71,75,116,346,350],"(IGF1R/IR)":[72,347],"androgen":[74,349],"(AR)":[76,351],"known":[78],"enriched":[81],"cross-communicate":[84],"in":[85,126,153,166,198,228,232,252,277,305,361,364,381],"subtypes":[86],"(Hamilton":[89],"N":[90,101],"et":[91,102],"al.,":[92,103],"Int":[93],"J":[94],"Mol":[95],"Sci":[96],"2017;18:2305":[97],"[PMCID:":[98,108],"PMC5713274];":[99],"Hamilton":[100],"Biomed":[104],"Res":[105],"Int.":[106],"2015;2015:925703":[107],"PMC4385615]),":[109],"we":[110],"first":[111],"assessed":[112],"effects":[113],"these":[115],"antagonists":[117,188,290,352],"on":[118,374],"proliferation":[119,142,182],"human":[121,144,201,273],"murine":[123,149,203],"cells":[125,152,205],"vitro.":[127],"Combination":[128,340],"treatment":[129],"BMS-754807":[131,241],"and/or":[132],"NVP-AEW541":[133],"(IGF1R/IR":[134],"inhibitors)":[135],"plus":[136],"enzalutamide":[137],"(AR":[138],"inhibitor)":[139],"effectively":[140],"reduced":[141,195],"MDA-MB-231,":[145],"BT549,":[146],"HCC1937":[147],"4T1":[150],"vitro":[154,199,362],"(P<0.001).":[155,189,279],"Moreover,":[156],"metformin":[157,161,266],"analogues":[159,267],"that":[162,256,283],"inhibit":[163,272],"progression":[165,276,360],"part":[167],"by":[168,309],"interactions":[169],"AMPK":[171],"IGFR1/IR":[174],"pathways":[175],"elicited":[176],"further":[177],"suppression":[178],"cell":[181,260],"when":[183],"combined":[184,293],"the":[186,191,196,219,306,370,375,385],"IGFR1/IR-AR":[187],"Importantly,":[190],"combination":[192,238,284],"also":[194,269],"migration":[197],"a":[207,254],"greater":[208],"extent":[209],"than":[210],"any":[211],"single":[212],"agent":[213],"given":[214],"alone.":[215],"Calculations":[216],"determine":[218],"coefficient":[220],"drug":[222,229],"interaction":[223],"(CDI)":[224],"revealed":[225],"therapeutic":[226],"synergy":[227],"combinations":[230],"predominantly":[231],"those":[233],"containing":[234,240,286],"BMS-754807.":[235],"Of":[236],"note,":[237],"were":[242],"found":[243,270],"significantly":[245],"stimulate":[246],"excess":[247],"reactive":[248],"oxygen":[249],"species":[250],"(ROS)":[251],"vitro,":[253],"process":[255],"may":[257],"promote":[258],"tumor":[259],"apoptosis.":[261],"In":[262],"ongoing":[263],"experiments,":[264],"novel":[265],"MDA-MB-231":[274],"xenograft":[275],"vivo":[278,365],"Our":[280],"findings":[281],"suggest":[282],"IGF1R/IR":[287],"AR":[289],"alone":[291],"metformins":[295,354],"suppress":[296],"progression,":[298],"potential":[300],"impact":[302],"patient":[303],"outcome":[304],"future.":[307],"[Funding":[308],"NCI":[310],"U54":[311],"CA1433930;":[312],"California":[313],"Breast":[314],"Cancer":[315,378,397],"Research":[316],"Program].":[317],"Citation":[318],"Format:":[319],"Nalo":[320],"M.":[321],"Hamilton,":[322],"PhD,":[323,332],"APRN-BC,":[324],"Diana":[325],"C.":[326],"M\u00e1rquez-Garb\u00e1n,":[327],"MD,":[328,338],"Michael":[329],"E.":[330],"Jung,":[331],"Jaydutt":[333],"Vadgama,":[334],"Richard":[335],"J.":[336],"Pietras,":[337],"PhD.":[339],"inhibits":[355],"triple-negative":[356],"[abstract].":[366],"In:":[367],"Proceedings":[368],"Twelfth":[371],"AACR":[372],"Conference":[373],"Science":[376],"Health":[379],"Disparities":[380],"Racial/Ethnic":[382],"Minorities":[383],"Medically":[386],"Underserved;":[387],"2019":[388],"Sep":[389],"20-23;":[390],"San":[391],"Francisco,":[392],"CA.":[393],"Philadelphia":[394],"(PA):":[395],"AACR;":[396],"Epidemiol":[398],"Biomarkers":[399],"Prev":[400],"2020;29(6":[401],"Suppl_2):Abstract":[402],"nr":[403],"D073.":[404]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2020-09-08T00:00:00"}